Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Janssen Sciences Ireland UC naming Leo Varadkar .
Filed returns
7
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Jan–Apr 2024 | Janssen Sciences Ireland UC | Health | Engagement with the Taoiseach on medicines access for patients in Ireland (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2023 | Janssen Sciences Ireland UC | Budgetary matters | Engagement with Government Ministers about Budget 2024 (Matters involving public funds) | 9 | On lobbying.ie |
| Jan–Apr 2022 | Janssen Sciences Ireland UC | Health | Sharing information on challenges in medicines reimbursement process in Ireland (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2022 | Janssen Sciences Ireland UC | Economic Development and Industry | Discussion on issues affecting biopharmaceutical and manufacturing technology industries in Ireland including specialised skills and talent, digital strategy, energy policy, healthcare and medicines policy (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2021 | Janssen Sciences Ireland UC | Economic Development and Industry | European Innovation Scorecard 2021 with a focus on Ireland’s performance and areas for improvement (Public policy or programme) | 6 | On lobbying.ie |
| Jan–Apr 2020 | Janssen Sciences Ireland UC | Economic Development and Industry | Briefing on business continuity plans during COVID-19 pandemic and progress on vaccine development as well as offering to support health service with expertise and capabilities (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2019 | Janssen Sciences Ireland UC | Health | Invite to visit Janssen garden ‘Grounded’ at Bloom in the Park festival (Public policy or programme) | 6 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Economic Development and Industry | 3 | 42.9% | |
| Health | 3 | 42.9% | |
| Budgetary matters | 1 | 14.3% |